Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Portola Pharmaceuticals Inc

+ Add to Watchlist

PTLA:US

41.8200 USD 0.2700 0.64%

As of 20:10:00 ET on 05/29/2015.

Snapshot for Portola Pharmaceuticals Inc (PTLA)

Open: 42.0000 Day's Range: 41.0200 - 42.7200 Volume: 840,169
Previous Close: 42.0900 52wk Range: 20.2360 - 43.6300 1-Yr Rtn: +88.72%

Stock Chart for PTLA

No chart data available.
  • PTLA:US 41.8200
  • 1D
  • 1M
  • 1Y
42.0900
Interactive PTLA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PTLA

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -3.3900
Est. EPS (USD) (12/2015) -4.3400
Est. PEG Ratio -
Market Cap (M USD) 2,176.69
Shares Outstanding (M) 52.05
30 Day Average Volume 324,959
Price/Book (mrq) 5.1941
Price/Sale (ttm) 194.5882
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PTLA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PTLA

Portola Pharmaceuticals, Inc. provides specialty pharmaceutical products. The Company offers novel therapeutics for thrombosis, hematologic disorders, and inflammation. Portola Pharmaceuticals serves customers in the United States.

William LisChief Executive OfficerMardi C DierExec VP/CFO
John T CurnutteExec VP:Research & DevAlexandra SantosDir:Investor Relations
More Company Profile & Key Executives for PTLA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil